| 对照组(n = 61) | 观察组(n = 93) | t/c² | P |
年龄(岁) | 62.77 ± 11.78 | 63.76 ± 9.01 | 0.560 | 0.577 |
男性[例(%)] | 43 (70.5) | 57 (61.3) | 1.370 | 0.242 |
吸烟史[例(%)] | 24 (39.3) | 32 (34.4) | 0.388 | 0.533 |
饮酒史[例(%)] | 19 (31.1) | 18 (19.4) | 2.807 | 0.094 |
合并疾病[例(%)] |
|
|
|
|
高血压 | 37 (60.7) | 50 (53.8) | 0.712 | 0.399 |
糖尿病 | 18 (29.5) | 32 (34.4) | 0.403 | 0.525 |
高脂血症 | 17 (27.9) | 28 (30.1) | 0.089 | 0.765 |
心衰基础病[例(%)] |
|
|
|
|
扩张性心肌病 | 22 (36.1) | 27 (29.0) | 0.840 | 0.359 |
缺血性心肌病 | 39 (63.9) | 66 (71.0) | 0.840 | 0.359 |
临床用药[例(%)] |
|
|
|
|
利尿剂 | 48 (78.7) | 73 (81.7) | 0.216 | 0.642 |
硝酸酯类 | 35 (57.4) | 59 (63.4) | 0.570 | 0.450 |
地高辛 | 29 (47.5) | 43 (46.2) | 0.025 | 0.874 |
β受体拮抗剂 | 43 (70.5) | 72 (77.4) | 0.935 | 0.334 |